L L Jelliffe-Pawlowski1,2, R J Baer1, Y J Blumenfeld3, K K Ryckman4, H M O'Brodovich5, J B Gould5,6, M L Druzin3, Y Y El-Sayed2, D J Lyell3, D K Stevenson5, G M Shaw5, R J Currier1. 1. Genetic Disease Screening Program, California Department of Public Health, Richmond, CA, USA. 2. Department of Epidemiology and Biostatistics, Division of Preventive Medicine and Public Health, University of California, San Francisco School of Medicine, San Francisco, CA, USA. 3. Department of Obstetrics & Gynecology, Stanford University School of Medicine, Stanford, CA, USA. 4. Department of Epidemiology, University of Iowa, Iowa City, IA, USA. 5. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. 6. California Perinatal Quality Care Collaborative, Palo Alto, CA, USA.
Abstract
OBJECTIVE: To examine the relationship between maternal characteristics, serum biomarkers and preterm birth (PTB) by spontaneous and medically indicated subtypes. DESIGN: Population-based cohort. SETTING: California, United States of America. POPULATION: From a total population of 1 004 039 live singleton births in 2009 and 2010, 841 665 pregnancies with linked birth certificate and hospital discharge records were included. METHODS: Characteristics were compared for term and preterm deliveries by PTB subtype using logistic regression and odds ratios adjusted for maternal characteristics and obstetric factors present in final stepwise models and 95% confidence intervals. First-trimester and second-trimester serum marker levels were analysed in a subset of 125 202 pregnancies with available first-trimester and second-trimester serum biomarker results. MAIN OUTCOME MEASURE: PTB by subtype. RESULTS: In fully adjusted models, ten characteristics and three serum biomarkers were associated with increased risk in each PTB subtype (Black race/ethnicity, pre-existing hypertension with and without pre-eclampsia, gestational hypertension with pre-eclampsia, pre-existing diabetes, anaemia, previous PTB, one or two or more previous caesarean section(s), interpregnancy interval ≥ 60 months, low first-trimester pregnancy-associated plasma protein A, high second-trimester α-fetoprotein, and high second-trimester dimeric inhibin A). These risks occurred in 51.6-86.2% of all pregnancies ending in PTB depending on subtype. The highest risk observed was for medically indicated PTB <32 weeks in women with pre-existing hypertension and pre-eclampsia (adjusted odds ratio 89.7, 95% CI 27.3-111.2). CONCLUSIONS: Our findings suggest a shared aetiology across PTB subtypes. These commonalities point to targets for further study and exploration of risk reduction strategies. TWEETABLE ABSTRACT: Findings suggest a shared aetiology across preterm birth subtypes. Patterns may inform risk reduction efforts.
OBJECTIVE: To examine the relationship between maternal characteristics, serum biomarkers and preterm birth (PTB) by spontaneous and medically indicated subtypes. DESIGN: Population-based cohort. SETTING: California, United States of America. POPULATION: From a total population of 1 004 039 live singleton births in 2009 and 2010, 841 665 pregnancies with linked birth certificate and hospital discharge records were included. METHODS: Characteristics were compared for term and preterm deliveries by PTB subtype using logistic regression and odds ratios adjusted for maternal characteristics and obstetric factors present in final stepwise models and 95% confidence intervals. First-trimester and second-trimester serum marker levels were analysed in a subset of 125 202 pregnancies with available first-trimester and second-trimester serum biomarker results. MAIN OUTCOME MEASURE: PTB by subtype. RESULTS: In fully adjusted models, ten characteristics and three serum biomarkers were associated with increased risk in each PTB subtype (Black race/ethnicity, pre-existing hypertension with and without pre-eclampsia, gestational hypertension with pre-eclampsia, pre-existing diabetes, anaemia, previous PTB, one or two or more previous caesarean section(s), interpregnancy interval ≥ 60 months, low first-trimester pregnancy-associated plasma protein A, high second-trimester α-fetoprotein, and high second-trimester dimeric inhibin A). These risks occurred in 51.6-86.2% of all pregnancies ending in PTB depending on subtype. The highest risk observed was for medically indicated PTB <32 weeks in women with pre-existing hypertension and pre-eclampsia (adjusted odds ratio 89.7, 95% CI 27.3-111.2). CONCLUSIONS: Our findings suggest a shared aetiology across PTB subtypes. These commonalities point to targets for further study and exploration of risk reduction strategies. TWEETABLE ABSTRACT: Findings suggest a shared aetiology across preterm birth subtypes. Patterns may inform risk reduction efforts.
Authors: Luz Gibbons; José M Belizan; Jeremy A Lauer; Ana P Betran; Mario Merialdi; Fernando Althabe Journal: Am J Obstet Gynecol Date: 2012-03-01 Impact factor: 8.661
Authors: Laura L Jelliffe-Pawlowski; Gary M Shaw; Robert J Currier; David K Stevenson; Rebecca J Baer; Hugh M O'Brodovich; Jeffrey B Gould Journal: Am J Obstet Gynecol Date: 2013-02-24 Impact factor: 8.661
Authors: Robert Currier; Nerissa Wu; Karla Van Meter; Sara Goldman; Fred Lorey; Monica Flessel Journal: Prenat Diagn Date: 2012-08-18 Impact factor: 3.050
Authors: Brandon W Alleman; Amanda R Smith; Heather M Byers; Bruce Bedell; Kelli K Ryckman; Jeffrey C Murray; Kristi S Borowski Journal: Am J Obstet Gynecol Date: 2013-03-15 Impact factor: 8.661
Authors: Brittney M Snyder; Rebecca J Baer; Scott P Oltman; Jennifer G Robinson; Patrick J Breheny; Audrey F Saftlas; Wei Bao; Andrea L Greiner; Knute D Carter; Larry Rand; Laura L Jelliffe-Pawlowski; Kelli K Ryckman Journal: Diabetes Res Clin Pract Date: 2020-04-06 Impact factor: 5.602
Authors: Jonathan G Shaw; D Alan Nelson; Kate A Shaw; Kelly Woolaway-Bickel; Ciaran S Phibbs; Lianne M Kurina Journal: Am J Epidemiol Date: 2018-04-01 Impact factor: 4.897
Authors: Jennifer N Felder; Elissa Epel; Jessica B Lewis; Shayna D Cunningham; Jonathan N Tobin; Sharon Schindler Rising; Melanie Thomas; Jeannette R Ickovics Journal: J Consult Clin Psychol Date: 2017-03-13
Authors: Samuel Parry; Benjamin A Carper; William A Grobman; Ronald J Wapner; Judith H Chung; David M Haas; Brian Mercer; Robert M Silver; Hyagriv N Simhan; George R Saade; Uma M Reddy; Corette B Parker Journal: Am J Obstet Gynecol Date: 2022-04-26 Impact factor: 10.693
Authors: Gretchen Bandoli; Namrata Singh; Jennifer Strouse; Rebecca J Baer; Brittney M Donovan; Sky K Feuer; Nichole Nidey; Kelli K Ryckman; Laura L Jelliffe-Pawlowski; Christina D Chambers Journal: Arthritis Care Res (Hoboken) Date: 2020-01-09 Impact factor: 4.794
Authors: Monica R McLemore; Rachel L Berkowitz; Scott P Oltman; Rebecca J Baer; Linda Franck; Jonathan Fuchs; Deborah A Karasek; Miriam Kuppermann; Safyer McKenzie-Sampson; Daphina Melbourne; Briane Taylor; Shanell Williams; Larry Rand; Brittany D Chambers; Karen Scott; Laura L Jelliffe-Pawlowski Journal: J Racial Ethn Health Disparities Date: 2020-10-09
Authors: Chelsea A Saito Reis; Justin G Padron; Nainoa D Norman Ing; Claire E Kendal-Wright Journal: Am J Reprod Immunol Date: 2020-09-17 Impact factor: 3.886